UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design

Gene therapy, 2011-07, Vol.18 (7), p.666-673

2011

Volltextzugriff (PDF)

Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain

Molecular psychiatry, 2013-08, Vol.18 (8), p.882-888

2013

Volltextzugriff (PDF)

Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein

Molecular psychiatry, 2017-07, Vol.22 (7), p.981-989

2017

Volltextzugriff (PDF)

Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

Molecular psychiatry, 2013-08, Vol.18 (8), p.889-897

2013

Volltextzugriff (PDF)

Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse

Molecular psychiatry, 2014-11, Vol.19 (11), p.1235-1242

2014

Volltextzugriff (PDF)

Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ

Molecular psychiatry, 2015-02, Vol.20 (1), p.109

2015

Volltextzugriff (PDF)

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular psychiatry, 2016-08, Vol.21 (8), p.1099

2016

Volltextzugriff (PDF)

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular psychiatry, 2016-08, Vol.21 (8), p.1153-1154

2016

Volltextzugriff (PDF)

Processing of Alzheimer β/A4 Amyloid Precursor Protein: Modulation by Agents that Regulate Protein Phosphorylation

Proceedings of the National Academy of Sciences - PNAS, 1990-08, Vol.87 (15), p.6003-6006

1990

Volltextzugriff (PDF)

Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro

Neuroscience, 1997-07, Vol.79 (2), p.509-516

1997

Volltextzugriff (PDF)

Expression of the Striatal DARPP-32/ARPP-21 Phenotype in GABAergic Neurons Requires Neurotrophins In Vivo and In Vitro

The Journal of neuroscience, 1999-07, Vol.19 (13), p.5409-5419

1999

Volltextzugriff (PDF)

DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle

American journal of physiology. Renal physiology, 1995-10, Vol.269 (4), p.564-F570

1995

Volltextzugriff (PDF)

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

The New England journal of medicine, 2017-06, Vol.376 (24), p.2341-2348

2017

Volltextzugriff (PDF)

Developmental regulation of phosphoprotein gene expression in the caudate-putamen of rat: An in situ hybridization study

Neuroscience, 1992-11, Vol.51 (1), p.65-75

1992

Volltextzugriff (PDF)

Mechanism of Inhibition of Protein Phosphatase 1 by DARPP-32: Studies with Recombinant DARPP-32 and Synthetic Peptides

Biochemical and biophysical research communications, 1995-01, Vol.206 (2), p.652-658

1995

Volltextzugriff (PDF)

ST14A Cells Have Properties of a Medium-Size Spiny Neuron

Experimental neurology, 2001-02, Vol.167 (2), p.215-226

2001

Volltextzugriff (PDF)

Mammalian Adrenal Chromaffin Cells Coexpress the Epinephrine-Synthesizing Enzyme and Neuronal Properties in Vivo and in Vitro

Developmental biology, 1994-06, Vol.163 (2), p.480-490

1994

Volltextzugriff (PDF)

Role of phosphatidylinositide 3‐kinase in brain‐derived neurotrophic factor‐induced DARPP‐32 expression in medium size spiny neurons in vitro

Journal of neurochemistry, 2001-12, Vol.79 (5), p.1027-1032

2001

Volltextzugriff (PDF)

Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse

Human molecular genetics, 2008-10, Vol.17 (20), p.3095-3104

2008

Volltextzugriff (PDF)

ARPP-21: murine gene structure and promoter identification of a neuronal phosphoprotein enriched in the limbic striatum

Brain research, 1996-02, Vol.709 (1), p.10-16

1996

Volltextzugriff (PDF)

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1[Delta]exon9 mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular psychiatry, 2016-08, Vol.21 (8), p.1153

2016

Volltextzugriff (PDF)

Erratum: Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology

Molecular psychiatry, 2016-08, Vol.21 (8), p.1153-1154

2016

Volltextzugriff (PDF)

Molecular systems evaluation of oligomerogenic APP super(E693Q) and fibrillogenic APP super(KM670/671NL)/PSEN1 super( Delta exon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular psychiatry, 2016-08, Vol.21 (8), p.1099-1111

2016

Volltextzugriff (PDF)

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1[Delta]exon9 mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular psychiatry, 2016-08, Vol.21 (8), p.1099

2016

Volltextzugriff (PDF)

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology

Molecular psychiatry, 2015-11, Vol.21 (8), p.1099-1111

2015

Volltextzugriff (PDF)

1 – 25 von 2.034

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.636)
Mit Volltextzugriff
(1.709)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design

Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain

Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein

Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model

Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse

Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular systems evaluation of oligomerogenic APP(E693Q) and fibrillogenic APP(KM670/671NL)/PSEN1(Δexon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Processing of Alzheimer β/A4 Amyloid Precursor Protein: Modulation by Agents that Regulate Protein Phosphorylation

Brain-derived neurotrophic factor regulates maturation of the DARPP-32 phenotype in striatal medium spiny neurons: studies in vivo and in vitro

Expression of the Striatal DARPP-32/ARPP-21 Phenotype in GABAergic Neurons Requires Neurotrophins In Vivo and In Vitro

DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

Developmental regulation of phosphoprotein gene expression in the caudate-putamen of rat: An in situ hybridization study

Mechanism of Inhibition of Protein Phosphatase 1 by DARPP-32: Studies with Recombinant DARPP-32 and Synthetic Peptides

ST14A Cells Have Properties of a Medium-Size Spiny Neuron

Mammalian Adrenal Chromaffin Cells Coexpress the Epinephrine-Synthesizing Enzyme and Neuronal Properties in Vivo and in Vitro

Role of phosphatidylinositide 3‐kinase in brain‐derived neurotrophic factor‐induced DARPP‐32 expression in medium size spiny neurons in vitro

Neocortical expression of mutant huntingtin is not required for alterations in striatal gene expression or motor dysfunction in a transgenic mouse

ARPP-21: murine gene structure and promoter identification of a neuronal phosphoprotein enriched in the limbic striatum

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1[Delta]exon9 mouse models identifies shared features with human Alzheimer's brain molecular pathology

Erratum: Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology

Molecular systems evaluation of oligomerogenic APP super(E693Q) and fibrillogenic APP super(KM670/671NL)/PSEN1 super( Delta exon9) mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1[Delta]exon9 mouse models identifies shared features with human Alzheimer's brain molecular pathology

Molecular systems evaluation of oligomerogenic APPE693Q and fibrillogenic APPKM670/671NL/PSEN1Δexon9 mouse models identifies shared features with human Alzheimer’s brain molecular pathology

Suchergebnisse filtern